Annual report pursuant to Section 13 and 15(d)

STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION (Tables)

v3.7.0.1
STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION (Tables)
 12 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of assumptions used in calculating fair values
The weighted-average fair values and the assumptions used in calculating fair values during each fiscal period are as follows:
 
For the year ended March 31,
 
2017
 
2016
 
2015
Option life (in years)
0.5

 
0.5

 
0.5

Risk-free interest rate
0.55
%
 
0.26
%
 
0.07
%
Stock price volatility
64.18
%
 
77.94
%
 
36.58
%
Weighted-average grant date fair value
$
2.11

 
$
2.32

 
$
2.88

Summary of share-based compensation expense
The following tables summarize share-based compensation expense (in thousands):
 
For the year ended March 31,
 
2017
 
2016
 
2015
Share-based compensation expense:
 
 
 
 
 
Cost of revenue
$
895

 
$
1,241

 
$
1,489

Research and development
1,300

 
1,864

 
2,559

Sales and marketing
2,255

 
2,907

 
3,506

General and administrative
2,248

 
2,904

 
4,029

Total share-based compensation expense
$
6,698

 
$
8,916

 
$
11,583

Schedule of share-based compensation by type of award
 
For the year ended March 31,
 
2017
 
2016
 
2015
Share-based compensation by type of award:
 
 
 
 
 
Stock options
$
—

 
$
2

 
$
617

Restricted stock
6,230

 
8,220

 
10,102

Stock purchase plan
468

 
694

 
864

Total share-based compensation expense
$
6,698

 
$
8,916

 
$
11,583

Schedule of activity relating to stock option plans
A summary of activity relating to all of our stock option plans is as follows (stock options in thousands):
 
Stock Options
 
Weighted-
Average
Exercise Price
 
Weighted-
Average
Remaining
Contractual Term
 
Aggregate
Intrinsic Value
Outstanding as of March 31, 2016
516

 
$
12.12

 
 
 
 
Exercised
—

 
—

 
 
 
 
Forfeited
(37
)
 
8.20

 
 
 
 
Expired
(299
)
 
8.01

 
 
 
 
Outstanding as of March 31, 2017
180

 
$
20.02

 
1.03
 
$
4,763

Vested and expected to vest at March 31, 2017
180

 
$
20.02

 
1.03
 
$
4,763

Exercisable as of March 31, 2017
180

 
$
20.02

 
1.03
 
$
4,763

Summary of information about stock options outstanding and exercisable
The following table summarizes information about stock options outstanding and exercisable as of March 31, 2017 (stock options in thousands):
Range of Exercise Prices
 
Stock Options
Outstanding
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual Life
(Years)
 
Stock Options
Exercisable
 
Weighted-
Average
Exercise
Price
$5.04
 
—
 
$
5.04

 
2

 
$
5.04

 
3.43
 
2

 
$
5.04

$20.16
 
—
 
$
23.20

 
178

 
$
20.23

 
1.00
 
178

 
$
20.23

 
 
 
 
 
 
180

 
 
 
 
 
180

 


Summary of activity relating to restricted stock
A summary of activity relating to our restricted stock is as follows (shares in thousands):
 
Shares
 
Weighted-Average
Grant Date
Fair Value
Nonvested as March 31, 2016
1,389

 
$
11.12

Granted
1,126

 
$
3.79

Vested
(693
)
 
$
10.80

Forfeited
(114
)
 
$
11.26

Nonvested as March 31, 2017
1,708

 
$
6.41